Market
Firefly to offer NeuroSigma’s non-drug ADHD device to clinicians
Firefly Neuroscience and NeuroSigma announced a partnership to distribute NeuroSigma's Monarch eTNS System, a non-pharmacological device for pediatric ADHD, to clinicians. The Monarch uses transcranial neurostimulation technology and represents a vendor collaboration to expand market reach for the cleared device.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network